Acta Diabetologica

, Volume 51, Issue 4, pp 609–616 | Cite as

Lower vitamin D levels at first trimester are associated with higher risk of developing gestational diabetes mellitus

  • Marilyn Lacroix
  • Marie-Claude Battista
  • Myriam Doyon
  • Ghislaine Houde
  • Julie Ménard
  • Jean-Luc Ardilouze
  • Marie-France Hivert
  • Patrice Perron
Original Article

Abstract

The progressive increase of insulin resistance observed in pregnancy contributes to the pathophysiology of gestational diabetes mellitus (GDM). There is controversy whether vitamin D deficiency contributes to abnormal glycemic regulation in pregnancy. We tested the associations between first trimester 25-hydroxyvitamin D (25OHD) levels and: 1) the risk of developing GDM; 2) insulin resistance/sensitivity, beta cell function and compensation indices in a large population-based prospective cohort of pregnant women. Participants (n = 655) were seen at first (6–13 weeks) and second (24–28 weeks) trimesters for blood samples. At first trimester, 25OHD levels were measured. At second trimester, glucose and insulin were measured 3 times during the oral glucose tolerance test to estimate insulin resistance (HOMA-IR), beta cell function (HOMA-B), insulin sensitivity (Matsuda index), insulin secretion (AUCins/gluc) and beta cell compensation (ISSI-2). Based on IADPSG criteria, 54 participants (8.2 %) developed GDM. Lower first trimester 25OHD levels were associated with higher risk of developing GDM even after adjustment for vitamin D confounding factors and GDM risk factors (OR = 1.48 per decrease of one SD in 25OHD levels; P = 0.04). Lower first trimester 25OHD levels were associated with higher HOMA-IR (r = − 0.08; P = 0.03), lower Matsuda index (r = 0.13; P = 0.001) and lower ISSI-2 (r = 0.08; P = 0.04). After adjustment for confounders, we found no significant association with HOMA-B and AUCins/gluc. Our results suggest that low levels of 25OHD at first trimester are (1) an independent risk factor for developing GDM and (2) associated with insulin resistance at second trimester.

Keywords

Insulin resistance Vitamin D 25OHD Pregnancy Gestational diabetes mellitus Prospective 

Supplementary material

592_2014_564_MOESM1_ESM.pdf (172 kb)
Supplementary material 1 (PDF 172 kb)
592_2014_564_MOESM2_ESM.pdf (152 kb)
Supplementary material 2 (PDF 151 kb)

References

  1. 1.
    Homko C, Sivan E, Chen X, Reece EA, Boden G (2001) Insulin secretion during and after pregnancy in patients with gestational diabetes mellitus. J Clin Endocrinol Metab 86:568–573PubMedGoogle Scholar
  2. 2.
    Evensen AE (2012) Update on gestational diabetes mellitus. Prim Care 39:83–94PubMedCrossRefGoogle Scholar
  3. 3.
    HAPO Study Cooperative Research Group, Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, Coustan DR, Hadden DR, McCance DR, Hod M, McIntyre HD, Oats JJ, Persson B, Rogers MS, Sacks DA (2008) Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 358:1991–2002PubMedCrossRefGoogle Scholar
  4. 4.
    Pittas AG, Lau J, Hu FB, Dawson-Hughes B (2007) The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 92:2017–2029PubMedCentralPubMedCrossRefGoogle Scholar
  5. 5.
    Liu E, Meigs JB, Pittas AG, Economos CD, McKeown NM, Booth SL, Jacques PF (2010) Predicted 25-hydroxyvitamin D score and incident type 2 diabetes in the Framingham Offspring Study. Am J Clin Nutr 91:1627–1633PubMedCentralPubMedCrossRefGoogle Scholar
  6. 6.
    Pittas AG, Sun Q, Manson JE, Dawson-Hughes B, Hu FB (2010) Plasma 25-hydroxyvitamin D concentration and risk of incident type 2 diabetes in women. Diabetes Care 33:2021–2023PubMedCentralPubMedCrossRefGoogle Scholar
  7. 7.
    Gagnon C, Lu ZX, Magliano DJ, Dunstan DW, Shaw JE, Zimmet PZ, Sikaris K, Grantham N, Ebeling PR, Daly RM (2011) Serum 25-hydroxyvitamin D, calcium intake, and risk of type 2 diabetes after 5 years: results from a national, population-based prospective study (the Australian Diabetes, Obesity and Lifestyle study). Diabetes Care 34:1133–1138PubMedCentralPubMedCrossRefGoogle Scholar
  8. 8.
    Khan H, Kunutsor S, Franco OH, Chowdhury R (2013) Vitamin D, type 2 diabetes and other metabolic outcomes: a systematic review and meta-analysis of prospective studies. Proc Nutr Soc 72:89–97PubMedCrossRefGoogle Scholar
  9. 9.
    Makgoba M, Nelson SM, Savvidou M, Messow CM, Nicolaides K, Sattar N (2011) First-trimester circulating 25-hydroxyvitamin D levels and development of gestational diabetes mellitus. Diabetes Care 34:1091–1093PubMedCentralPubMedCrossRefGoogle Scholar
  10. 10.
    Baker AM, Haeri S, Camargo CA Jr, Stuebe AM, Boggess KA (2012) First-trimester maternal vitamin D status and risk for gestational diabetes (GDM) a nested case-control study. Diabetes Metab Res Rev 28:164–168PubMedGoogle Scholar
  11. 11.
    Zhang C, Qiu C, Hu FB, David RM, van Dam RM, Bralley A, Williams MA (2008) Maternal plasma 25-hydroxyvitamin D concentrations and the risk for gestational diabetes mellitus. PLoS ONE 3:e3753PubMedCentralPubMedCrossRefGoogle Scholar
  12. 12.
    Parlea L, Bromberg IL, Feig DS, Vieth R, Merman E, Lipscombe LL (2012) Association between serum 25-hydroxyvitamin D in early pregnancy and risk of gestational diabetes mellitus. Diabet Med 29(7):e25–32 Google Scholar
  13. 13.
    Poel YH, Hummel P, Lips P, Stam F, van der Ploeg T, Simsek S (2012) Vitamin D and gestational diabetes: a systematic review and meta-analysis. Eur J Intern Med 23:465–469PubMedCrossRefGoogle Scholar
  14. 14.
    Christesen HT, Falkenberg T, Lamont RF, Jorgensen JS (2012) The impact of vitamin D on pregnancy: a systematic review. Acta Obstet Gynecol Scand 91:1357–1367PubMedCrossRefGoogle Scholar
  15. 15.
    Aghajafari F, Nagulesapillai T, Ronksley PE, Tough SC, O’Beirne M, Rabi DM (2013) Association between maternal serum 25-hydroxyvitamin D level and pregnancy and neonatal outcomes: systematic review and meta-analysis of observational studies. BMJ 346:f1169PubMedCrossRefGoogle Scholar
  16. 16.
    Canadian Diabetes Association (2008) Can J Diabetes 2012:201Google Scholar
  17. 17.
    Anonymous (2004) Canadian Community Health Survey, Cycle 2.2. Nutrition (2004) A guide to accessing and interpreting the data. 2012Google Scholar
  18. 18.
    Lacroix M, Battista MC, Doyon M, Menard J, Ardilouze JL, Perron P, Hivert MF (2013) Lower adiponectin levels at first trimester of pregnancy are associated with increased insulin resistance and higher risk of developing gestational diabetes mellitus. Diabetes Care 36:1577–1583PubMedCentralPubMedCrossRefGoogle Scholar
  19. 19.
    International Association of Diabetes and Pregnancy Study Groups Consensus Panel, Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PA, Damm P, Dyer AR, Leiva A, Hod M, Kitzmiler JL, Lowe LP, McIntyre HD, Oats JJ, Omori Y, Schmidt MI (2010) International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 33:676–682CrossRefGoogle Scholar
  20. 20.
    Aronov PA, Hall LM, Dettmer K, Stephensen CB, Hammock BD (2008) Metabolic profiling of major vitamin D metabolites using Diels-Alder derivatization and ultra-performance liquid chromatography-tandem mass spectrometry. Anal Bioanal Chem 391:1917–1930PubMedCentralPubMedCrossRefGoogle Scholar
  21. 21.
    Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM, Endocrine Society (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96:1911–1930PubMedCrossRefGoogle Scholar
  22. 22.
    Gagnon C, Baillargeon JP, Desmarais G, Fink GD (2010) Prevalence and predictors of vitamin D insufficiency in women of reproductive age living in northern latitude. Eur J Endocrinol 163:819–824PubMedCrossRefGoogle Scholar
  23. 23.
    Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419PubMedCrossRefGoogle Scholar
  24. 24.
    Wallace TM, Levy JC, Matthews DR (2004) Use and abuse of HOMA modeling. Diabetes Care 27:1487–1495PubMedCrossRefGoogle Scholar
  25. 25.
    Matsuda M, DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22:1462–1470PubMedCrossRefGoogle Scholar
  26. 26.
    Retnakaran R, Shen S, Hanley AJ, Vuksan V, Hamilton JK, Zinman B (2008) Hyperbolic relationship between insulin secretion and sensitivity on oral glucose tolerance test. Obesity (Silver Spring) 16:1901–1907CrossRefGoogle Scholar
  27. 27.
    Retnakaran R, Qi Y, Goran MI, Hamilton JK (2009) Evaluation of proposed oral disposition index measures in relation to the actual disposition index. Diabet Med 26:1198–1203PubMedCrossRefGoogle Scholar
  28. 28.
    Zhao G, Ford ES, Li C (2010) Associations of serum concentrations of 25-hydroxyvitamin D and parathyroid hormone with surrogate markers of insulin resistance among US adults without physician-diagnosed diabetes: NHANES, 2003–2006. Diabetes Care 33:344–347PubMedCentralPubMedCrossRefGoogle Scholar
  29. 29.
    McLeod DS, Warner JV, Henman M, Cowley D, Gibbons K, McIntyre HD, for the HAPO Study Cooperative Research Group (2012) Associations of serum vitamin D concentrations with obstetric glucose metabolism in a subset of the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study cohort. Diabet Med 29(8):e199–204Google Scholar
  30. 30.
    Clifton-Bligh RJ, McElduff P, McElduff A (2008) Maternal vitamin D deficiency, ethnicity and gestational diabetes. Diabet Med 25:678–684PubMedCrossRefGoogle Scholar
  31. 31.
    Talaei A, Mohamadi M, Adgi Z (2013) The effect of vitamin D on insulin resistance in patients with type 2 diabetes. Diabet Metab Syndr 5(1):8 Google Scholar
  32. 32.
    Belenchia AM, Tosh AK, Hillman LS, Peterson CA (2013) Correcting vitamin D insufficiency improves insulin sensitivity in obese adolescents: a randomized controlled trial. Am J Clin Nutr 97:774–781PubMedCrossRefGoogle Scholar
  33. 33.
    Mitri J, Dawson-Hughes B, Hu FB, Pittas AG (2011) Effects of vitamin D and calcium supplementation on pancreatic beta cell function, insulin sensitivity, and glycemia in adults at high risk of diabetes: the Calcium and Vitamin D for Diabetes Mellitus (CaDDM) randomized controlled trial. Am J Clin Nutr 94:486–494PubMedCentralPubMedCrossRefGoogle Scholar
  34. 34.
    Nagpal J, Pande JN, Bhartia A (2009) A double-blind, randomized, placebo-controlled trial of the short-term effect of vitamin D3 supplementation on insulin sensitivity in apparently healthy, middle-aged, centrally obese men. Diabet Med 26:19–27PubMedCrossRefGoogle Scholar
  35. 35.
    Soheilykhah S, Mojibian M, Moghadam MJ, Shojaoddiny-Ardekani A (2013) The effect of different doses of vitamin D supplementation on insulin resistance during pregnancy. Gynecol Endocrinol 29:396–399PubMedCrossRefGoogle Scholar
  36. 36.
    Asemi Z, Samimi M, Tabassi Z, Shakeri H, Esmaillzadeh A (2013) Vitamin D supplementation affects serum high-sensitivity C-reactive protein, insulin resistance, and biomarkers of oxidative stress in pregnant women. J Nutr 143:1432–1438PubMedCrossRefGoogle Scholar
  37. 37.
    Cekmez F, Aydemir G, Aydinoz S, Pirgon O, Genc FA, Tunc T, Sarici SU (2012) Low 25-hydroxyvitamin D level and adiponectin is associated with insulin sensitivity in large gestational age infants. Cytokine 59:156–158PubMedCrossRefGoogle Scholar
  38. 38.
    Marcotorchino J, Gouranton E, Romier B, Tourniaire F, Astier J, Malezet C, Amiot MJ, Landrier JF (2012) Vitamin D reduces the inflammatory response and restores glucose uptake in adipocytes. Mol Nutr Food Res 56:1771–1782PubMedCrossRefGoogle Scholar
  39. 39.
    Alkharfy KM, Al-Daghri NM, Yakout SM, Ahmed M (2013) Calcitriol attenuates weight-related systemic inflammation and ultrastructural changes in the liver in a rodent model. Basic Clin Pharmacol Toxicol 112:42–49PubMedCrossRefGoogle Scholar
  40. 40.
    Alkharfy KM, Al-Daghri NM, Yakout SM, Hussain T, Mohammed AK, Krishnaswamy S (2013) Influence of vitamin D treatment on transcriptional regulation of insulin-sensitive genes. Metab Syndr Relat Disord 11:283–288PubMedCrossRefGoogle Scholar
  41. 41.
    Kirwan JP, Huston-Presley L, Kalhan SC, Catalano PM (2001) Clinically useful estimates of insulin sensitivity during pregnancy: validation studies in women with normal glucose tolerance and gestational diabetes mellitus. Diabetes Care 24:1602–1607PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2014

Authors and Affiliations

  • Marilyn Lacroix
    • 1
  • Marie-Claude Battista
    • 1
  • Myriam Doyon
    • 2
  • Ghislaine Houde
    • 1
    • 2
  • Julie Ménard
    • 2
  • Jean-Luc Ardilouze
    • 1
    • 2
  • Marie-France Hivert
    • 1
    • 2
    • 3
  • Patrice Perron
    • 1
    • 2
    • 4
  1. 1.Faculty of Medicine and Health SciencesUniversité de SherbrookeSherbrookeCanada
  2. 2.Centre de recherche clinique Étienne-Le BelCentre hospitalier universitaire de SherbrookeSherbrookeCanada
  3. 3.Department of Population MedicineHarvard Pilgrim Health Care InstituteBostonUSA
  4. 4.Division of Endocrinology, Department of MedicineCentre hospitalier universitaire de SherbrookeSherbrookeCanada

Personalised recommendations